fashion -WSS

fashion

author：comprehensive 2025-10-01 00:59:06 - browse：1

Apellis Pharmaceuticals said Tuesday that it had identified “internal structural variations” in a type of needle used by doctors to prepare syringes of its eye disease drug Syfovre as a possible cause of severe eye inflammation reported in patients receiving the treatment — but the company stopped short of definitively linking the needle to the cases.

Additionally, Apellis confirmed one additional case of the severe and potentially blinding side effect, known as retinal occlusive vasculitis, or ROV, that occurred in May. But with thousands of more Syfovre eye injections also performed, the overall frequency of ROV remains unchanged and rare, even with the added scrutiny and increased physician monitoring.

Apellis shares rose 30% to $40 in Wednesday’s pre-market trading on the growing belief amongst investors that Syfovre’s safety crisis is abating.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： FDA poised to publish guidelines for clinical trial diversity

entertainment

WSS

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Study finds gene variants tied to breast cancer risk in Black women

New company forms to vet health AI models, root out weaknesses

ASCO eve: Let’s set the table for this year's meeting

New company forms to vet health AI models, root out weaknesses

Biogen joins immunology wave with $1.15 billion acquisition of HI

focus

fashion

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Lifetime voting ban for felony convictions struck down in Mississippi

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

New company forms to vet health AI models, root out weaknesses

Heart attack and stroke risk calculators need revising

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Supreme Court strikes down use of affirmative action

Eyeing GLP

Walensky prepares to leave CDC — and Congress — behind

For longer

entertainment

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

Liver decline slowed by off

Digital health: a case of mistaken identity

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Investigation reveals sickle cell patients pressured into sterilizations

Biogen joins immunology wave with $1.15 billion acquisition of HI

focus

entertainment

Wikipedia

explore